Hollencrest Capital Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,157
Closed -$31.2K 1155
2025
Q1
$31.2K Hold
1,157
﹤0.01% 592
2024
Q4
$33.1K Hold
1,157
﹤0.01% 605
2024
Q3
$31.1K Sell
1,157
-1,150
-50% -$30.3K ﹤0.01% 589
2024
Q2
$64.1K Hold
2,307
﹤0.01% 468
2024
Q1
$63.8K Buy
2,307
+1,342
+139% +$35.1K ﹤0.01% 443
2023
Q4
$23.5K Hold
965
﹤0.01% 606
2023
Q3
$21.6K Hold
965
﹤0.01% 614
2023
Q2
$24.7K Hold
965
﹤0.01% 615
2023
Q1
$22.8K Hold
965
﹤0.01% 616
2022
Q4
$21.1K Buy
+965
New +$23.8K ﹤0.01% 600
2022
Q2
Sell
-6,797
Closed -$266K 358
2022
Q1
$266K Sell
6,797
-300
-4% -$11.6K 0.02% 278
2021
Q4
$325K Sell
7,097
-100
-1% -$4.77K 0.03% 264
2021
Q3
$341K Hold
7,197
0.03% 248
2021
Q2
$333K Hold
7,197
0.03% 253
2021
Q1
$316K Hold
7,197
0.03% 257
2020
Q4
$295K Hold
7,197
0.03% 250
2020
Q3
$269K Buy
7,197
+100
+1% +$3.69K 0.03% 237
2020
Q2
$245K Sell
7,097
-653
-8% -$20.3K 0.03% 226
2020
Q1
$217K Buy
7,750
+750
+11% +$25K 0.03% 237
2019
Q4
$244K Buy
+7,000
New +$237K 0.03% 257

Other funds holding FFTY

Hollencrest Capital Management's FFTY Position: Q2 2025 in Review

Hollencrest Capital Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2025, closing a stake of 1,157 shares — an estimated $31.2K sold.

Hollencrest Capital Management first reported a position in FFTY in Q4 2019 and held it in 20 quarters. The position peaked at $341K in Q3 2021. 38 funds tracked by Wall St. Rank hold FFTY as of Q2 2025.

  • Hollencrest Capital Management reported no remaining CapForce IBD 50 ETF position as of Q2 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 1,157 CapForce IBD 50 ETF shares in Q2 2025, an estimated $31.2K.
  • Hollencrest Capital Management first reported a position in CapForce IBD 50 ETF in Q4 2019 and held it in 20 quarters.
  • Hollencrest Capital Management's CapForce IBD 50 ETF position peaked at $341K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2025.

Based on Hollencrest Capital Management's 13F filing for Q2 2025, filed 18 Aug 2025.